Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 250.0 [1] | |
| CFTR(inh)-172 | IC50 | 300.0 [1], 380.0 [2] | |
| BPO-27 (racemate) | IC50 | 8.0 [1], 40.0 [2] | |
| 9-(5-Bromofuran-2-yl)-12,14-dimethyl-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 90.0 [1], 200.0 [2] | |
| 9-(5-Bromofuran-2-yl)-12,14-dimethyl-4-nitro-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 25.0 [1], 120.0 [2] | |
MLA | "Quest Database™ Cystic fibrosis transmembrane conductance regulator Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 6 Feb. 2026, https://www.aatbio.com/data-sets/cystic-fibrosis-transmembrane-conductance-regulator-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, February 6). Quest Database™ Cystic fibrosis transmembrane conductance regulator Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cystic-fibrosis-transmembrane-conductance-regulator-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |